Chugai Pharmaceutical, JP3519400000

Chugai Pharmaceutical stock has October 27 results due ahead of Xetra open

Published on 10/22/2026 at 08:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Chugai's IR materials cover research, products and its development pipeline. At Lang & Schwarz the stock trades pre-market at EUR 37.54 on October 22, 2026.

Upcoming Results and Trading

  • The company's third-quarter results are scheduled for October 27, 2026.
  • The scheduled IR events begin at 5:00 p.m. JST and continue at 6:00 p.m. JST.
  • Chugai Pharmaceutical stock trades pre-market at EUR 37.54 at 8:14 a.m. CEST at Lang & Schwarz on October 22, 2026.
Chugai Pharmaceutical, JP3519400000, Illustration mit AI erstellt.

Chugai Pharmaceutical's investor-relations page lists fiscal 2026 third-quarter results for October 27, 2026, with a results conference scheduled for the same day. The page also shows Chugai Pharmaceutical stock trading pre-market at EUR 37.54 at 8:14 a.m. CEST on October 22, 2026 at Lang & Schwarz.

Results scheduled for October 27

The company lists its third-quarter results for fiscal 2026 at 5:00 p.m. Japan Standard Time on October 27, followed by a conference at 6:00 p.m. JST. The schedule is published on Chugai Pharmaceutical's investor-relations page.

Pre-market trading before Xetra

Bid was EUR 37.33 and ask was EUR 37.75, a spread of 1.12 percent. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Chugai Pharmaceutical stock.

Research and pharmaceutical products

Chugai's investor-relations materials present its activities through research and development, products, its development pipeline and technology. The October 27 schedule includes the results release and a related conference, as listed on the company's IR site. Market context: Market report Nikkei 225.

More news and analysis on Chugai Pharmaceutical stock

Disclaimer...
en | JP3519400000 | CHUGAI PHARMACEUTICAL | boerse | 70390640 | bgmi